GE Healthcare has received clearance from the U.S. Food and Drug Administration (FDA) for its latest image-guided system (IGS) for interventional cardiology, Allia IGS Pulse. Allia IGS Pulse runs on the company’s Allia Platform and was designed with interventional cardiologists in mind. The angiography system includes a monopolar X-ray tube for acquiring the cardiac images needed to treat of a variety of cardiovascular conditions. It also can capture images of large and bariatric patients who may be associated with certain challenges due to their size.